OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts

BackgroundBladder cancer lacks useful and robust prognostic markers to stratify patients at risk. Our study is to identify a robust prognostic marker for bladder cancer.MethodsThe transcriptome and clinical data of bladder cancer were downloaded from multiple databases. We searched for genes with ro...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiaxing Lin, Xiao Xu, Tianren Li, Jihang Yao, Meng Yu, Yuyan Zhu, Dan Sun
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
Online Access:https://doaj.org/article/4fe6067f241f4b4e80ca4e57ea018ddf
Tags: Add Tag
No Tags, Be the first to tag this record!